URINARY β-CORE hCG: SCREENING FOR ANEUPLOIDIES IN EARLY PREGNANCY (11-14 WEEKS' GESTATION)

Initial studies at 17–22 weeks' gestation evaluating urinary β‐core human chorionic gonadotrophin (hCG) as a marker for Down's syndrome had suggested that it may have more potential than its serum counterpart. This study measured maternal urinary β‐core‐hCG and creatinine at 11–14 weeks�...

Ausführliche Beschreibung